Compare LGND & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGND | GNW |
|---|---|---|
| Founded | 1987 | 1871 |
| Country | United States | United States |
| Employees | 68 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | N/A | 2004 |
| Metric | LGND | GNW |
|---|---|---|
| Price | $232.28 | $8.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $245.86 | $10.50 |
| AVG Volume (30 Days) | 179.0K | ★ 3.0M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $7,301,000,000.00 |
| Revenue This Year | $1.61 | N/A |
| Revenue Next Year | $18.93 | N/A |
| P/E Ratio | $76.27 | ★ $15.91 |
| Revenue Growth | N/A | ★ 0.08 |
| 52 Week Low | $98.90 | $6.29 |
| 52 Week High | $227.92 | $9.28 |
| Indicator | LGND | GNW |
|---|---|---|
| Relative Strength Index (RSI) | 72.23 | 57.05 |
| Support Level | $179.55 | $8.30 |
| Resistance Level | N/A | $8.80 |
| Average True Range (ATR) | 8.46 | 0.21 |
| MACD | 2.20 | 0.07 |
| Stochastic Oscillator | 94.85 | 70.04 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has four main operating business segments: Enact, Closed Block segment, and Corporate and Other. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. The majority of the revenue is generated by the Enact segment. The company earns the maximum of its revenue in the United States.